A history and general assessment of the patients is mandatory to exclude pathology and evaluate various factors which may influence choice and success of management. Evaluation of systems such as ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2024 and recent business highlights.

Moreover, a dysfunction of the autonomic nervous system can be induced as a side effect of drug treatment interacting. When dysautonomia is prominent or compared early in the clinical course of ...